FibroBiologics Stock (NASDAQ: FBLG) stock price, news, charts, stock research, profile.
Open | $1.45 |
Close | $1.58 |
Volume / Avg. | 226.35K / 308.70K |
Day Range | $1.39 - $1.69 |
52 Wk Range | 1.08 - 55.00 |
Market Cap | $49.22M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 2.17% |
Days to Cover | 6.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of FibroBiologics (NASDAQ:FBLG) through any online brokerage.
Other companies in FibroBiologics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA) and Intensity Therapeutics (NASDAQ:INTS).
There is no analysis for FibroBiologics to provide a consensus price target.
The stock price for FibroBiologics (NASDAQ: FBLG) is $1.4 last updated August 23, 2024 at 9:29 AM EDT.
There are no upcoming dividends for FibroBiologics.
FibroBiologics’s Q3 earnings are confirmed for Saturday, November 2, 2024.
There is no upcoming split for FibroBiologics.
FibroBiologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.